RECORDATI RARE FDA Approval NDA 022562

NDA 022562

RECORDATI RARE

FDA Drug Application

Application #022562

Documents

Review2010-04-20
Letter2010-03-22
Letter2013-08-06
Label2010-03-18
Label2013-08-05
Label2017-11-17
Letter2017-11-17
Letter2019-12-26
Label2019-12-31
Letter2020-08-27
Letter2021-01-25
Letter2021-01-25
Label2021-01-28
Label2021-01-28
Label2021-08-06
Letter2021-08-06

Application Sponsors

NDA 022562RECORDATI RARE

Marketing Status

Prescription001

Application Products

001TABLET;ORAL200MG1CARBAGLUCARGLUMIC ACID

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP2010-03-18PRIORITY
LABELING; LabelingSUPPL2AP2013-08-05STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP2014-01-23PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL4AP2015-11-05PRIORITY
LABELING; LabelingSUPPL5AP2017-11-16STANDARD
EFFICACY; EfficacySUPPL8AP2021-01-22PRIORITY
EFFICACY; EfficacySUPPL9AP2021-01-22PRIORITY
LABELING; LabelingSUPPL11AP2019-12-23STANDARD
LABELING; LabelingSUPPL12AP2020-08-26STANDARD
LABELING; LabelingSUPPL13AP2021-08-05STANDARD

Submissions Property Types

ORIG1Null6
SUPPL2Null7
SUPPL3Null14
SUPPL4Null14
SUPPL5Null7
SUPPL8Null6
SUPPL9Null6
SUPPL11Null6
SUPPL12Null6
SUPPL13Orphan5

TE Codes

001PrescriptionAB

CDER Filings

RECORDATI RARE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 22562
            [companyName] => RECORDATI RARE
            [docInserts] => ["",""]
            [products] => [{"drugName":"CARBAGLU","activeIngredients":"CARGLUMIC ACID","strength":"200MG","dosageForm":"TABLET, FOR SUSPENSION;ORAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"12\/23\/2019","submission":"SUPPL-11","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/022562s011lbl.pdf\"}]","notes":""},{"actionDate":"11\/16\/2017","submission":"SUPPL-5","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/022562s005lbl.pdf\"}]","notes":""},{"actionDate":"08\/05\/2013","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/022562s002lbl.pdf\"}]","notes":""},{"actionDate":"03\/18\/2010","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/022562lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"CARBAGLU","submission":"CARGLUMIC ACID","actionType":"200MG","submissionClassification":"TABLET, FOR SUSPENSION;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2019-12-23
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.